Company profile

CUTISS AG

CUTISS grows human skin in the lab for patients that suffer from skin defects (e.g. burns). CUTISS bio-engineers individually customized human skin starting off from a very small piece of patient’s skin. Because CUTISS’ skin closely resembles human skin, minimal scarring occurs after surgery.

Source: startup.ch

Highlights

Top 100 Swiss Startup Award 2021

Top 100 Swiss Startup Award 2020

Top 100 Swiss Startup Award 2019

Top 100 Swiss Startup Award 2018

Top 100 Swiss Startup Award 2017

Innosuisse Certificate

More news about CUTISS AG

29.11.2023 10:00

Swiss medtech startups enter next development phase

Success

25.10.2023 16:00

Swiss startups in the spotlight: a global media perspective

Background

19.05.2023 13:10

Cash and honorary awards for Swiss innovators

Award

28.04.2023 15:06

Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million

Support

03.04.2023 13:40

Positive from CUTISS’ Phase I and Phase II clinical studies

Success

09.03.2022 15:45

CUTISS graduates from Wyss Zurich with onsite facility for denovoSkin production

Expansion

25.01.2022 11:00

CUTISS secures French government grant and opens R&D site in France

Expansion

Support

09.09.2021 07:44

TOP 100 Swiss Startup Award celebrates Switzerland’s most promising startups

Award

06.07.2021 16:40

Promising results from first compassionate use of CUTISS’ denovoSkin in Switzerland

Success

25.05.2021 09:05

CUTISS’ denovoSkin first large scale transplantation delivers proof of principle

Success

20.10.2020 16:19

New management at life sciences start-ups

Expansion

10.09.2020 08:32

Cutiss leads the ranking of the Top 100 Swiss Startup Award

Award

05.08.2020 09:05

Cutiss’ bio-engineered skin approved to save children’s lives

Background

Success

29.06.2020 10:45

CUTISS closes series B funding

Financing

05.06.2020 08:02

CUTISS raises CHF18.7 million

Financing

17.01.2020 13:02

Eight Swiss startups among the finalists of the Hello Tomorrow Challenge

Award

21.11.2019 17:13

FenX und Cutiss mit Swiss Technology Award 2019 ausgezeichnet

Award

08.11.2019 12:07

IPO Day: Deep-tech companies on stage

Financing

Support

08.11.2019 10:58

Sechs Startups unter den Finalisten des Swiss Technology Award

Award

29.10.2019 10:59

Biotech startups strengthen their teams

Background

20.09.2019 14:01

Cutiss’ CEO Daniela Marino wins “Female Innovator of the Year Award”

Award

Support

19.08.2019 09:02

Cutiss and CSEM work on a skin-tissue producing machine

Support

31.07.2018 10:40

Three Swiss startups receive SME Instrument funds

Financing

27.06.2018 09:05

UZH spinoff raises CHF 7.2 million in a series A round

Financing

04.06.2018 13:45

Boston: strong Swiss presence at the Swiss Biotech pavilion

Support

05.04.2018 13:40

Venture Leaders show the innovative power of the Swiss life sciences sector

Award

10.11.2017 12:19

CTI Start-up Label for three amazing companies

Award

06.11.2017 10:00

CUTISS receives Swissmedic approval for Phase II trials

Success

30.08.2017 09:55

UZH Life Sciences Fund invests in first spin-off

Financing

18.05.2017 17:16

W. A. de Vigier awards five start-ups

Award

Founded
2017

Kanton
ZH

Homepage

Principal

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.